Jeremy Sullivan
Jeremy Sullivan is an investment adviser at Hamilton Hindin Green, recognized for his insights into the financial markets. Recently, he commented on the rationale behind Ryman Healthcare's $1 billion equity raise, describing it as 'warranted' and 'fundamentally attractive' for investors due to the company's debt situation.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Jeremy Sullivan is an investment adviser who commented on Fonterra's sale and its implications for farmers.
8
New Zealand:
Jeremy Sullivan said the manufacturing issues could potentially lead to delays in a2 Milk getting its product to market.
5
New Zealand:
Jeremy Sullivan said the sale buyers were all lining up.
7
New Zealand:
Jeremy Sullivan said the economy is taking longer to recover than companies such as Fletcher would like.
5
New Zealand:
Jeremy Sullivan is an investment adviser who commented on the legal situation involving Fletcher and SkyCity.
5
New Zealand:
Jeremy Sullivan said Meridian did the heavy lifting.
7
New Zealand:
Jeremy Sullivan is an investment adviser who commented on the financial situation of Pacific Edge.
5
New Zealand:
Jeremy Sullivan, an investment adviser at Hamilton Hindin Greene, said the pandemic led to mass cancellations and many people opted for credits instead of refunds at the time.
7
New Zealand:
Jeremy Sullivan, investment adviser with Hamilton Hindin Greene, said the OCR cut was already priced into the local market.
7
New Zealand:
Investment adviser Jeremy Sullivan said people were wasting money on buying Lotto tickets.
6